RxDoctor Payments Data

Krestana Hart

Nurse Practitioner · Lady Lake, FLNPI 1669525234

Payments from drug & device makers

$14,488in general payments, 2019–2025

Across 281 payments — averaging $51.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Boston Scientific$4K
  • Curonix LLC$1K
  • Collegium Pharmaceutical, Inc.$908
  • AbbVie$645
  • Averitas Pharma Inc.$316
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$6,28843%
  • Food & beverage$8,14656%
  • Education$540%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,488 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$241,115
Medicare patients
287
Services billed
2,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate39$21,634
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl103$10,710
Tramadol Hcl685$8,383
Pregabalin157$8,021
Buprenorphine29$7,168
Gabapentin425$5,835
Duloxetine Hcl85$4,006
Buprenorphine Hcl59$3,499
Tramadol Hcl ErTramadol Hcl48$3,024
Tizanidine Hcl219$2,570
Lidocaine23$2,339
Cyclobenzaprine Hcl204$1,743
Lubiprostone16$1,479
Methocarbamol90$1,341
Metaxalone16$1,313

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Virtus Pharmaceuticals LLCLactulose$20$1,03042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Lady Lake

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →